{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T15:58:54Z","timestamp":1733327934512,"version":"3.30.1"},"update-to":[{"updated":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"DOI":"10.1371\/journal.pcbi.1006952","type":"new_version","label":"New version"}],"reference-count":94,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37AI054165"],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI068635"],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1006952","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T13:33:39Z","timestamp":1554125619000},"page":"e1006952","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features"],"prefix":"10.1371","volume":"15","author":[{"given":"Craig A.","family":"Magaret","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1019-8343","authenticated-orcid":true,"given":"David C.","family":"Benkeser","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-548X","authenticated-orcid":true,"given":"Brian D.","family":"Williamson","sequence":"additional","affiliation":[]},{"given":"Bhavesh R.","family":"Borate","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0333-5925","authenticated-orcid":true,"given":"Lindsay N.","family":"Carpp","sequence":"additional","affiliation":[]},{"given":"Ivelin S.","family":"Georgiev","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4726-6132","authenticated-orcid":true,"given":"Ian","family":"Setliff","sequence":"additional","affiliation":[]},{"given":"Adam S.","family":"Dingens","sequence":"additional","affiliation":[]},{"given":"Noah","family":"Simon","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Carone","sequence":"additional","affiliation":[]},{"given":"Christopher","family":"Simpkins","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-6319","authenticated-orcid":true,"given":"David","family":"Montefiori","sequence":"additional","affiliation":[]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[]},{"given":"Wen-Han","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Michal","family":"Juraska","sequence":"additional","affiliation":[]},{"given":"Paul T.","family":"Edlefsen","sequence":"additional","affiliation":[]},{"given":"Shelly","family":"Karuna","sequence":"additional","affiliation":[]},{"given":"Nyaradzo M.","family":"Mgodi","sequence":"additional","affiliation":[]},{"given":"Srilatha","family":"Edugupanti","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-9427","authenticated-orcid":true,"given":"Peter B.","family":"Gilbert","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"issue":"5993","key":"ref1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"X Wu","year":"2010","journal-title":"Science"},{"issue":"5993","key":"ref2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"T Zhou","year":"2010","journal-title":"Science"},{"issue":"7365","key":"ref3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"LM Walker","year":"2011","journal-title":"Nature"},{"issue":"6151","key":"ref4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1241144","article-title":"Antibodies in HIV-1 vaccine development and therapy","volume":"341","author":"F Klein","year":"2013","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-041015-055515","article-title":"Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design","volume":"34","author":"DR Burton","year":"2016","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/COH.0000000000000153","article-title":"HIV broadly neutralizing antibody targets","volume":"10","author":"CK Wibmer","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"e1000955","DOI":"10.1371\/journal.pcbi.1000955","article-title":"Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies","volume":"6","author":"S Gnanakaran","year":"2010","journal-title":"PLoS Comput Biol"},{"issue":"W1","key":"ref8","doi-asserted-by":"crossref","first-page":"W213","DOI":"10.1093\/nar\/gkv404","article-title":"CATNAP: a tool to compile, analyze and tally neutralizing antibody panels","volume":"43","author":"H Yoon","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"ref9","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.1128\/JVI.00754-11","article-title":"Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01","volume":"85","author":"Y Li","year":"2011","journal-title":"J Virol"},{"issue":"7475","key":"ref10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12746","article-title":"Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia","volume":"503","author":"M Shingai","year":"2013","journal-title":"Nature"},{"issue":"7475","key":"ref11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"DH Barouch","year":"2013","journal-title":"Nature"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.virol.2012.06.025","article-title":"Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model","volume":"432","author":"M Veselinovic","year":"2012","journal-title":"Virology"},{"issue":"7427","key":"ref13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"F Klein","year":"2012","journal-title":"Nature"},{"issue":"21","key":"ref14","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMp1613362","article-title":"Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy","volume":"375","author":"M Caskey","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11904-016-0299-7","article-title":"Broadly Neutralizing Antibodies for HIV Eradication","volume":"13","author":"KE Stephenson","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"319","key":"ref16","doi-asserted-by":"crossref","first-page":"319ra206","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection","volume":"7","author":"RM Lynch","year":"2015","journal-title":"Sci Transl Med"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cei.12692","article-title":"Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults","volume":"182","author":"JE Ledgerwood","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"21","key":"ref18","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","volume":"375","author":"KJ Bar","year":"2016","journal-title":"N Engl J Med"},{"key":"ref19","unstructured":"Mayer K, Seaton K, Huang Y, Grunenberg N, Hural J, Ledgerwood J, et al., editors. Clinical Safety and Pharmacokinetics of IV and SC VRC01, a Broadly Neutralizing mAb. Conference on Retroviruses and Opportunistic Infections (CROI); 2016 Feb 22\u201325, 2016; Boston, Massachusetts."},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","DOI":"10.1515\/scid-2016-0001","article-title":"Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials","volume":"9","author":"PB Gilbert","year":"2017","journal-title":"Statistical Communications in Infectious Diseases"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0895-4356(00)00258-4","article-title":"Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation","volume":"54","author":"P Gilbert","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/654816","article-title":"Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine","volume":"202","author":"P Gilbert","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1541-0420.2007.00845.x","article-title":"Genome scanning tests for comparing amino acid sequences between groups","volume":"64","author":"PB Gilbert","year":"2008","journal-title":"Biometrics"},{"issue":"7420","key":"ref24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature11519","article-title":"Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2","volume":"490","author":"M Rolland","year":"2012","journal-title":"Nature"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nm.2316","article-title":"Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial","volume":"17","author":"M Rolland","year":"2011","journal-title":"Nat Med"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"e1003973","DOI":"10.1371\/journal.pcbi.1003973","article-title":"Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial","volume":"11","author":"PT Edlefsen","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"47","key":"ref27","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1016\/j.vaccine.2016.09.054","article-title":"A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial","volume":"34","author":"T Hertz","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/rssc.12067","article-title":"Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trials","volume":"64","author":"PB Gilbert","year":"2015","journal-title":"J R Stat Soc Ser C Appl Stat"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/biom.12016","article-title":"Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy","volume":"69","author":"M Juraska","year":"2013","journal-title":"Biometrics"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic Diversity and Protective Efficacy of the RTS,S\/AS01 Malaria Vaccine","volume":"373","author":"DE Neafsey","year":"2015","journal-title":"N Engl J Med"},{"issue":"36","key":"ref31","doi-asserted-by":"crossref","first-page":"E8378","DOI":"10.1073\/pnas.1714250115","article-title":"Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials","volume":"115","author":"M Juraska","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"e0185959","DOI":"10.1371\/journal.pone.0185959","article-title":"Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120","volume":"12","author":"AC deCamp","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00117832","article-title":"Stacked Regressions","volume":"24","author":"L Breiman","year":"1996","journal-title":"Machine Learning"},{"issue":"1","key":"ref34","article-title":"Super Learner","volume":"6","author":"MJ van der Laan","year":"2007","journal-title":"Stat Appl Genet Mol"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-2600(14)70239-5","article-title":"Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study","volume":"3","author":"R Pirracchio","year":"2015","journal-title":"Lancet Resp Med"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/QAI.0000000000000548","article-title":"Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring","volume":"69","author":"ML Petersen","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref37","article-title":"Statistical inference for data adaptive target parameters","author":"MJ van der Laan","year":"2013","journal-title":"UC Berkeley Division of Biostatistics Working Paper Series"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1214\/15-EJS1035","article-title":"Computationally efficient confidence intervals for cross-validated area under the ROC curve estimates","volume":"9","author":"E LeDell","year":"2015","journal-title":"Electron J Statist"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-9782-1","article-title":"Targeted learning: causal inference for observational and experimental data. Chapter 3","author":"MJ Van der Laan","year":"2011"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2144\/000113370","article-title":"DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites","volume":"48","author":"W Deng","year":"2010","journal-title":"Biotechniques"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1128\/JVI.03608-14","article-title":"HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies","volume":"89","author":"RM Lynch","year":"2015","journal-title":"J Virol"},{"issue":"51","key":"ref42","doi-asserted-by":"crossref","first-page":"43170","DOI":"10.1074\/jbc.M112.399402","article-title":"A single residue within the V5 region of HIV-1 envelope facilitates viral escape from the broadly neutralizing monoclonal antibody VRC01","volume":"287","author":"D Guo","year":"2012","journal-title":"J Biol Chem"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"e1003738","DOI":"10.1371\/journal.ppat.1003738","article-title":"Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes","volume":"9","author":"CK Wibmer","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1742-4690-11-32","article-title":"Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site","volume":"11","author":"P Utachee","year":"2014","journal-title":"Retrovirology"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"e80562","DOI":"10.1371\/journal.pone.0080562","article-title":"Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data","volume":"8","author":"AL Ferguson","year":"2013","journal-title":"PLoS One"},{"issue":"26","key":"ref46","first-page":"10598","article-title":",","volume":"110","author":"AP West Jr.","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-15-77","article-title":"Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method","volume":"15","author":"MC Evans","year":"2014","journal-title":"BMC Bioinformatics"},{"issue":"18","key":"ref48","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1128\/JVI.00984-13","article-title":"Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains","volume":"87","author":"GY Chuang","year":"2013","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"W64","DOI":"10.1093\/nar\/gku318","article-title":"NEP: web server for epitope prediction based on antibody neutralization of viral strains with diverse sequences","volume":"42","author":"GY Chuang","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"ref50","article-title":"Nonparametric variable importance assessment using machine learning techniques","author":"BD Williamson","year":"2019","journal-title":"Biometrics"},{"issue":"6","key":"ref51","first-page":"2884","article-title":"Native Conformation and Canonical Disulfide Bond Formation Are Interlinked Properties of HIV-1","volume":"90","author":"EP Go","year":"2015","journal-title":"Env Glycoproteins. J Virol"},{"issue":"16","key":"ref52","doi-asserted-by":"crossref","first-page":"14531","DOI":"10.1074\/jbc.M111.224527","article-title":"Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China","volume":"286","author":"H Shang","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.pmed.0050009","article-title":"Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41","volume":"5","author":"CA Blish","year":"2008","journal-title":"PLoS Med"},{"issue":"22","key":"ref54","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1128\/JVI.01352-12","article-title":"Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodies","volume":"86","author":"SM O'Rourke","year":"2012","journal-title":"J Virol"},{"issue":"15","key":"ref55","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1128\/JVI.00688-09","article-title":"Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies","volume":"83","author":"SM O'Rourke","year":"2009","journal-title":"J Virol"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"e1006093","DOI":"10.1371\/journal.pcbi.1006093","article-title":"Exploiting glycan topography for computational design of Env glycoprotein antigenicity","volume":"14","author":"WH Yu","year":"2018","journal-title":"PLoS Comput Biol"},{"issue":"7377","key":"ref57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10696","article-title":"Structure of HIV-1 gp120 V1\/V2 domain with broadly neutralizing antibody PG9","volume":"480","author":"JS McLellan","year":"2011","journal-title":"Nature"},{"issue":"30","key":"ref58","first-page":"E2083","article-title":",","volume":"109","author":"AP West Jr.","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ref59","doi-asserted-by":"crossref","first-page":"e1005789","DOI":"10.1371\/journal.pcbi.1005789","article-title":"Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time","volume":"13","author":"A Hake","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"1\u20132","key":"ref60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jim.2011.09.007","article-title":"Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells","volume":"375","author":"CA Todd","year":"2012","journal-title":"J Immunol Methods"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01762-16","article-title":"Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies","volume":"91","author":"HM Cheeseman","year":"2017","journal-title":"J Virol"},{"issue":"14","key":"ref62","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1128\/JVI.00171-11","article-title":"An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum","volume":"85","author":"G Ferrari","year":"2011","journal-title":"J Virol"},{"issue":"11","key":"ref63","doi-asserted-by":"crossref","first-page":"e1002435","DOI":"10.1371\/journal.pmed.1002435","article-title":"Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial","volume":"14","author":"KH Mayer","year":"2017","journal-title":"PLoS Med"},{"issue":"19","key":"ref64","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1128\/JVI.01414-12","article-title":"A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection","volume":"86","author":"L Goo","year":"2012","journal-title":"J Virol"},{"issue":"12","key":"ref65","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/bip.360221211","article-title":"Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features","volume":"22","author":"W Kabsch","year":"1983","journal-title":"Biopolymers"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"D411","DOI":"10.1093\/nar\/gkq1105","article-title":"A series of PDB related databases for everyday needs","volume":"39","author":"RP Joosten","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","article-title":"Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies","volume":"39","author":"T Zhou","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"ref68","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2016.04.010","article-title":"Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G","volume":"165","author":"GB Stewart-Jones","year":"2016","journal-title":"Cell"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.virol.2017.02.024","article-title":"Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction","volume":"505","author":"ET Crooks","year":"2017","journal-title":"Virology"},{"issue":"5","key":"ref70","doi-asserted-by":"crossref","first-page":"e1004932","DOI":"10.1371\/journal.ppat.1004932","article-title":"Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site","volume":"11","author":"ET Crooks","year":"2015","journal-title":"PLoS Pathog"},{"issue":"12","key":"ref71","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1089\/aid.2005.21.1016","article-title":"Covariability of selected amino acid positions for HIV type 1 subtypes C and B","volume":"21","author":"PB Gilbert","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ebiom.2016.08.045","article-title":"Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity","volume":"12","author":"T Bradley","year":"2016","journal-title":"EBioMedicine"},{"issue":"9","key":"ref73","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1128\/JVI.74.9.4183-4191.2000","article-title":"Jr. A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex","volume":"74","author":"EJ Park","year":"2000","journal-title":"J Virol"},{"issue":"5","key":"ref74","doi-asserted-by":"crossref","first-page":"e37157","DOI":"10.1371\/journal.pone.0037157","article-title":"Association of enhanced HIV-1 neutralization by a single Y681H substitution in gp41 with increased gp120-CD4 interaction and macrophage infectivity","volume":"7","author":"R Ringe","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref75","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/JVI.68.2.674-680.1994","article-title":"Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change","volume":"68","author":"M Thali","year":"1994","journal-title":"J Virol"},{"issue":"7","key":"ref76","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1128\/JVI.64.7.3240-3248.1990","article-title":"The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope","volume":"64","author":"C Wilson","year":"1990","journal-title":"J Virol"},{"issue":"1","key":"ref77","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/viro.1993.1484","article-title":"An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(\u2014>Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site","volume":"196","author":"PJ Klasse","year":"1993","journal-title":"Virology"},{"issue":"11","key":"ref78","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1128\/JVI.67.11.6897-6902.1993","article-title":"Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies","volume":"67","author":"NK Back","year":"1993","journal-title":"J Virol"},{"issue":"40","key":"ref79","first-page":"17","article-title":"The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins","author":"RD Marshall","year":"1974","journal-title":"Biochem Soc Symp"},{"issue":"7","key":"ref80","doi-asserted-by":"crossref","first-page":"e1005742","DOI":"10.1371\/journal.ppat.1005742","article-title":"Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization","volume":"12","author":"C Rademeyer","year":"2016","journal-title":"PLoS Pathog"},{"issue":"2","key":"ref81","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-5193(86)80075-3","article-title":"The Classification of Amino-Acid Conservation","volume":"119","author":"WR Taylor","year":"1986","journal-title":"J Theor Biol"},{"issue":"5","key":"ref82","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth","volume":"45","author":"J Huang","year":"2016","journal-title":"Immunity"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1038\/ncomms9443","article-title":"Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies","volume":"6","author":"NE Webb","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"ref84","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the Lasso","volume":"58","author":"R Tibshirani","year":"1996","journal-title":"J Roy Stat Soc B Met"},{"journal-title":"glmnet: Lasso and Elastic-Net Regularized Generalized Linear Models","article-title":"glmnet: Lasso and Elastic-Net Regularized Generalized Linear Models","author":"J Friedman","key":"ref85"},{"issue":"3","key":"ref86","first-page":"18","article-title":"Classification and regression by randomForest","volume":"2","author":"A Liaw","year":"2002","journal-title":"R news"},{"journal-title":"randomForest: Breiman and Cutler's Random Forests for Classification and Regression","article-title":"randomForest: Breiman and Cutler's Random Forests for Classification and Regression","author":"A Liaw","key":"ref87"},{"key":"ref88","unstructured":"John GH, Langley P, editors. Estimating continuous distributions in Bayesian classifiers. Proceedings of the Eleventh conference on Uncertainty in artificial intelligence; 1995: Morgan Kaufmann Publishers Inc."},{"journal-title":"e1071: Misc Functions of the Department of Statistics, Probability Theory Group (Formerly: E1071), TU Wien","article-title":"e1071: Misc Functions of the Department of Statistics, Probability Theory Group (Formerly: E1071), TU Wien","author":"D Meyer","key":"ref89"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C, editors. XGBoost: A scalable tree boosting system. 22nd SIGKDD Conference on Knowledge Discovery and Data Mining; 2016: ACM.","DOI":"10.1145\/2939672.2939785"},{"journal-title":"xgboost: eXtreme Gradient Boosting","article-title":"xgboost: eXtreme Gradient Boosting","author":"T Chen","key":"ref91"},{"key":"ref92","unstructured":"R-core R-core@R-project.org<\/ext-link>. https:\/\/wwwrdocumentationorg\/packages\/stats\/versions\/343\/topics\/glm<\/ext-link>. stats v3.4.3."},{"issue":"2","key":"ref93","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0893-6080(05)80023-1","article-title":"Stacked Generalization","volume":"5","author":"DH Wolpert","year":"1992","journal-title":"Neural Networks"},{"key":"ref94","article-title":"vimp: R package to go along with theoretical work on a nonparametric variable importance parameter","author":"BD Williamson","year":"2017","journal-title":"vimp: R package to go along with theoretical work on a nonparametric variable importance parameter"}],"updated-by":[{"updated":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"DOI":"10.1371\/journal.pcbi.1006952","type":"new_version","label":"New version"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T09:34:19Z","timestamp":1721122459000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006952"}},"subtitle":[],"editor":[{"given":"Nico","family":"Pfeifer","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":94,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1006952","relation":{},"ISSN":["1553-7358"],"issn-type":[{"type":"electronic","value":"1553-7358"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}